GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi India Ltd (BOM:500674) » Definitions » EV-to-FCF

Sanofi India (BOM:500674) EV-to-FCF : (As of May. 27, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Sanofi India EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sanofi India's Enterprise Value is ₹199,669 Mil. Sanofi India's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0 Mil. Therefore, Sanofi India's EV-to-FCF for today is .

The historical rank and industry rank for Sanofi India's EV-to-FCF or its related term are showing as below:

BOM:500674' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 104.06
Current: 101.82

During the past 13 years, the highest EV-to-FCF of Sanofi India was 104.06. The lowest was 0.00. And the median was 0.00.

BOM:500674's EV-to-FCF is ranked worse than
87.5% of 528 companies
in the Drug Manufacturers industry
Industry Median: 24.695 vs BOM:500674: 101.82

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), Sanofi India's stock price is ₹8832.75. Sanofi India's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹261.780. Therefore, Sanofi India's PE Ratio for today is 33.74.


Sanofi India EV-to-FCF Historical Data

The historical data trend for Sanofi India's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi India EV-to-FCF Chart

Sanofi India Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.69 31.56 31.10 33.18 92.83

Sanofi India Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.18 - - - 92.83

Competitive Comparison of Sanofi India's EV-to-FCF

For the Drug Manufacturers - General subindustry, Sanofi India's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanofi India's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanofi India's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Sanofi India's EV-to-FCF falls into.



Sanofi India EV-to-FCF Calculation

Sanofi India's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=199668.726/0
=

Sanofi India's current Enterprise Value is ₹199,669 Mil.
Sanofi India's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sanofi India  (BOM:500674) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Sanofi India's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=8832.75/261.780
=33.74

Sanofi India's share price for today is ₹8832.75.
Sanofi India's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹261.780.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Sanofi India EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Sanofi India's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanofi India (BOM:500674) Business Description

Traded in Other Exchanges
Address
Saki Vihar Road, Sanofi House, CTS Number 117-B, L&T Business Park, Powai, Mumbai, MH, IND, 400072
Sanofi India Ltd is a drug manufacturing company that focuses on a range of therapeutic areas, including Diabetes, Cardiology, Consumer Healthcare, Hospital, Central Nervous System, and Anti-Histamines. The company's diabetes presence includes oral anti-diabetic products and insulin. The consumer healthcare area also maintains a nutraceutical portfolio. The company's export markets include Germany, the U.K., Australia, and Russia. The company utilizes strategic partnerships as a component of its growth strategy.

Sanofi India (BOM:500674) Headlines

No Headlines